3 Bromopyruvate - Cancer Science

Relevant Publications

3-bromopyruvate induces morphological alteration and may initiate programmed cell death in Cryptococcus neoformans cells.

Issue Release: 2024

Immunogenic Cell Death Induction and Oxygenation by Multifunctional Hollow Silica/Copper-Doped Carbon Dots.

Issue Release: 2024

Nanoscale Metal-Organic Layer Reprograms Cellular Metabolism to Enhance Photodynamic Therapy and Antitumor Immunity.

Issue Release: 2024

SOX2 and OCT4 mediate radiation and drug resistance in pancreatic tumor organoids.

Issue Release: 2024

S100A8/9 modulates perturbation and glycolysis of macrophages in allergic asthma mice.

Issue Release: 2024

Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia.

Issue Release: 2024

CAR T Cell Membrane Camouflaged Nanocatalyst Augments CAR T Cell Therapy Efficacy Against Solid Tumor.

Issue Release: 2024

S100A8/9 modulates perturbation and glycolysis of macrophages in allergic asthma mice.

Issue Release: 2024

Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer.

Issue Release: 2024

Stimuli-responsive cancer nanomedicines inhibit glycolysis and impair redox homeostasis.

Issue Release: 2023

Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis.

Issue Release: 2023

Inhibition of Key Glycolytic Enzyme Hexokinase 2 Ameliorates Psoriasiform Inflammation in vitro and in vivo.

Issue Release: 2023

Interfering biosynthesis by nanoscale metal-organic frameworks for enhanced radiation therapy.

Issue Release: 2023

Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response.

Issue Release: 2023

3-Bromopyruvate-Loaded TiC MXene/CuO Nanosheets for Photoacoustic Imaging-Guided and Hypoxia-Relieving Enhanced Photothermal/Chemodynamic Therapy.

Issue Release: 2023

Biomimetic nanovesicle co-delivery system impairs energy metabolism for cancer treatment.

Issue Release: 2023

3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis.

Issue Release: 2023

Correction to: Glycolytic inhibitors 2-deoxyglucose and 3-bromopyruvate synergize with photodynamic therapy respectively to inhibit cell migration.

Issue Release: 2023

ROS mediated anticandidal efficacy of 3-Bromopyruvate prevents vulvovaginal candidiasis in mice model.

Issue Release: 2023

Multimodal Imaging of Pancreatic Cancer Microenvironment in Response to an Antiglycolytic Drug.

Issue Release: 2023

What role do biomarkers play in cancer treatment?

How Do Blister Packs Benefit Cancer Patients?

How to Prepare for Bone Marrow Aspiration?

What are the Benefits of Telemedicine in Cancer Care?

Which Types of Cancer Are Most Commonly Associated with Dysphagia?

How do Keratins Affect Tumor Behavior?

Which Cancers are Associated with MSI-H?

What are the Challenges in Using Natural Compounds for Cancer Treatment?

How is Processed Meat Linked to Cancer?

Why is Tumor Location Important in Cancer?

Partnered Content Networks

Relevant Topics